Stephens Consulting’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.12K | Buy |
+7
| New | +$3.12K | ﹤0.01% | 438 |
|
|
2025
Q1 | – | Sell |
-55
| Closed | -$22.1K | – | 1553 |
|
|
2024
Q4 | $22.1K | Hold |
55
| – | – | 0.01% | 265 |
|
|
2024
Q3 | $25.6K | Sell |
55
-12
| -18% | -$5.58K | 0.01% | 239 |
|
|
2024
Q2 | $31.4K | Buy |
+67
| New | +$31.4K | 0.01% | 222 |
|
|
2022
Q4 | – | Sell |
-132
| Closed | -$38.2K | – | 564 |
|
|
2022
Q3 | $38.2K | Hold |
132
| – | – | 0.03% | 192 |
|
|
2022
Q2 | $37.2K | Hold |
132
| – | – | 0.03% | 193 |
|
|
2022
Q1 | $34.4K | Sell |
132
-161
| -55% | -$42K | 0.03% | 217 |
|
|
2021
Q4 | $64.3K | Buy |
+293
| New | +$64.3K | 0.05% | 172 |
|